AAA Analysis – Page 78

Analysis: Boehringer Ingelheim starts 2018 with $300m fund

Pharmaceutical firm Boehringer Ingelheim has committed €150m in capital to its corporate venturing vehicle, Boehringer Ingelheim Venture Fund (BIVF), increasing its total investment in the fund to €250m ($300m). BIVF typically provides between €10m and €15m to each portfolio company in totL, where initial commitments vary between €500,000 and €3m. Its investment areas are focused… Continue reading Analysis: Boehringer Ingelheim starts 2018 with $300m fund

Teaser from the World of Corporate Venturing 2018 survey

GCV Analytics conducted its annual survey on the state of the corporate venturing industry in October and November 2017. A total of 60 respondents participated. The response rate was slightly lower than in previous years due to the considerable additional length and depth of the survey (we asked over 40 questions this time). However, we… Continue reading Teaser from the World of Corporate Venturing 2018 survey